Immunogenicity of transgenic plant-derived hepatitis B surface antigen. - Wikidata - wikimedia - TriplyDB

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

http://www.wikidata.org/entity/Q34437147

about

Virus-like particles production in green plants The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B Induced immunity against hepatitis B virus A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65).Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus.Immunogenicity in humans of an edible vaccine for hepatitis B.Oral immunization with hepatitis B surface antigen expressed in transgenic plants.Vaccination strategies for mucosal immune responses Transgenic plants as factories for biopharmaceuticals.Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.Plant-based vaccines against viruses.Foods as production and delivery vehicles for human vaccines.Proteomic analysis of tomato (Lycopersicum esculentum var. cerasifarm) expressing the HBsAg gene by 2-dimensional difference gel electrophoresis.Expression of immunogenic S1 glycoprotein of infectious bronchitis virus in transgenic potatoes.Plant-derived vaccines against diarrhoeal diseases.Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccines Transgenic plants in the biopharmaceutical market.Vaccination strategies for the prevention of cervical cancer.Oral hepatitis B vaccine candidates produced and delivered in plant material.Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces.Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead.The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects?Plant-derived virus-like particles as vaccines Chloroplast-derived vaccine antigens and biopharmaceuticals: expression, folding, assembly and functionality.Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice Transgenic plant-based oral vaccines.Plant-made immunogens and effective delivery strategies.Plant-based vaccines against human hepatitis B virus.Virus-like particles produced in plants as potential vaccines.Recent advances and safety issues of transgenic plant-derived vaccines.Plant-derived pharmaceuticals for the developing world.Current status of viral expression systems in plants and perspectives for oral vaccines development.Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants.The therapeutic potential of plant-derived vaccines and antibodies.Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form.Induction of a dwarf phenotype with IBH1 may enable increased production of plant-made pharmaceuticals in plant factory conditions.Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products.Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts.High-yield expression of a viral peptide vaccine in transgenic plants.Expression and immunogenicity of an Escherichia coli K99 fimbriae subunit antigen in soybean.

P2860

Q24650772-6ECDBE85-48B4-4C00-BC83-08418EC6B181 Q28073401-61D73592-E0AD-4B51-BB11-BFAF99D548BD Q28080525-D0F27F1E-7506-46C3-B442-96AD093A1A6E Q33385000-3265B1CD-2583-40DD-BEC1-11E520B3A907 Q33648566-CF5B7880-40D6-4877-95A3-9D534B1381D4 Q33858661-3D24132A-53B8-4582-9E68-E01655D4C85F Q33944696-CA6F8302-1DE1-464B-8EE6-5F8749CFCD04 Q33975703-D1DC31CB-7E54-41E2-95DC-9E621D35DE6D Q34076132-FAC09B29-D62C-4367-B1E5-20786CDBC0A2 Q34240349-F6A026F9-6446-4D74-9BF4-C9908E2273E0 Q34687464-2FB68C06-4FCF-4299-B149-F25AEE1BA257 Q34692460-7EE69159-259E-472D-AED6-0EF631CDB075 Q34994010-C8701FDB-116A-433C-9E12-B1BC2322BA19 Q35182159-57D8548C-FF3C-46F8-BF96-E1B7A83BBF12 Q35779390-8D8BA3B8-2683-4AA8-9174-95034116DB2D Q35966608-15345719-244A-4CC4-A9DE-826F9675C5DF Q36066053-0ADD9434-FAAB-4BC7-9093-E488F73F11DF Q36066161-A4103414-541B-4C2C-8917-4D35EE00C981 Q36118497-5087FF73-916E-4621-B231-017822E58FF8 Q36228727-E6A59AB1-BA41-4389-8983-49F4C9FFAB27 Q36445550-C7D61FBE-5B96-483F-A98B-EC50783EE5A6 Q36590168-79EA4137-79FC-4F7D-BB81-7593EEBC6A6A Q36888029-1F3F00F9-EC7D-4218-8353-84FC82FF0A73 Q37393185-DB3DF77E-4737-4737-8902-8E36E3CC3410 Q37584470-7EE247FA-7A8D-4404-9C12-65C58DFB8CF7 Q37744913-67C64778-100B-4B22-A2DA-FA5FDCC20A55 Q37776713-ADE2058D-B1B7-4086-879D-539E5D7EE11D Q37776722-F26C535C-0A0E-422E-9DB3-7DB766CD75B0 Q38081975-8BCF52D2-C630-429D-9A77-95AFAA985433 Q38085252-CBA6676A-C915-4179-BF92-B861BB5FA038 Q38121856-543BBC2D-61FF-4BBA-A933-C4CAE6A92BD7 Q38307990-B25D218F-5709-471C-B90B-D675C8F369C8 Q39642504-C45AE2DC-729F-4405-AA7C-38B4AB432898 Q40408971-3AD78A2A-FD76-4192-9D8E-1A47BEBE2F58 Q40694013-23CD26EA-38C8-4354-B703-EE5692B84CC0 Q40719670-58736844-2AF5-456F-9259-EED214B65CCA Q41819883-AC7DA3AD-EF6A-45AC-98FD-DF786DFF796C Q41947780-8A7BF2C6-04C0-4120-A3C6-82D64C56A0E0 Q44911177-E08481D9-CF3C-42C8-9BE6-20938CB9018E Q45194179-B09E104C-7567-498D-B790-38D5AD84DA56

P2860

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

http://www.wikidata.org/entity/Q34437147

description

1995 nî lūn-bûn

@nan

1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@ast

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@en

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@nl

type

label

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@ast

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@en

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@nl

prefLabel

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@ast

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@en

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@nl

P1433

Q34437147-E8A59D07-8748-4D51-81BB-07680EC2912F

P1476

Q34437147-9D54CE10-1E68-4732-A792-101DB76226B2

P2093

Q34437147-4C49EE50-E8F1-440B-8BA0-08EE93803F1A

Q34437147-502621C4-122F-4A6A-A42C-005FF98789B4

Q34437147-52F1DD8C-9962-4740-86BB-2D526CD1CCDB

Q34437147-7B9E3E3A-6D0A-43EE-99CC-E7A482ACC0CB

Q34437147-8D3BFF54-9076-40EF-9293-9A40F596B789

P2860

Q34437147-1352B7A3-D133-40E0-B6A8-2D6A0D0AFBB9

Q34437147-2E198E14-4769-45DB-B848-3EF4F1E1C02D

Q34437147-6491F691-B648-404C-A108-D037B04CA0BB

Q34437147-A5C01770-338B-47CC-9149-8251F83B4B63

Q34437147-F1C3FFF0-F962-4C92-B417-70D4E3F7C723

P304

Q34437147-B14A298B-85E1-4581-92E9-3AE1E6CB8DA8

P31

Q34437147-A706AC49-EA6A-4112-9694-7D6B6B63CC4C

P356

Q34437147-0E544AB6-3A1C-4E09-9EF4-7B2D73F9AB4D

P407

Q34437147-09EF197F-64BB-451F-998B-0DD8E746E2DC

P433

Q34437147-941DB430-688C-4A53-AF28-E8E49E7F397F

P478

Q34437147-65BF89B0-674F-474C-B8FA-4FB124F631F0

P577

Q34437147-12D1B111-456E-4C17-A306-B9A1873C12D7

P5875

Q34437147-04B0A8F6-4F22-4857-9C05-888852F5417C

P698

Q34437147-3CB0A4FA-9E4C-4ECD-8369-D1734CB16F2D

P932

Q34437147-54D4C1CA-B1EF-4AB6-9792-17AC3544B8FF

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Immunogenicity of transgenic plant-derived hepatitis B surface antigen.

@en

P2093

C Arntzen

http://www.w3.org/2001/XMLSchema#string

H S Mason

http://www.w3.org/2001/XMLSchema#string

P Lyons

http://www.w3.org/2001/XMLSchema#string

Y F Yang

http://www.w3.org/2001/XMLSchema#string

Y Thanavala

http://www.w3.org/2001/XMLSchema#string

P2860

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Hepatitis viruses: changing patterns of human disease

Mimicry of the a determinant of hepatitis B surface antigen by an antiidiotypic antibody. I. Evaluation in hepatitis B surface antigen responder and nonresponder strains.

Expression of hepatitis B surface antigen in transgenic plants

Molecular mimicry of hepatitis B surface antigen by an anti-idiotype-derived synthetic peptide.

P304

3358-3361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.92.8.3358

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

1995-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15473754

http://www.w3.org/2001/XMLSchema#string

P698

7724566

http://www.w3.org/2001/XMLSchema#string

P932

42165

http://www.w3.org/2001/XMLSchema#string